Skip to content

OptimizeRx OPRX Interest coverage

Interest coverage at other companies

Veeva Systems logo
Veeva SystemsVEEV
5.5×0.0×
Phreesia logo
PhreesiaPHR
0.4×+0.2×
GoodRx Holdings, Inc. logo
GoodRx Holdings, Inc.GDRX
1.9×+0.2×
PubMatic logo
PubMaticPUBM
-1.9×-2.9×
Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
-8.6×
National Research Corporation logo
National Research CorporationNRC
4.7×-8.8×

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Calculated from OptimizeRx’s reported figures.

Based on trailing twelve months.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's interest coverage?
OptimizeRx (OPRX) reported interest coverage of 2.8× in Q1 2026.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.